Yihong Zhou, Tao Lu, Yan Li, Yuanyuan Qin, Yanqiu Lu, Qun Tian, Ke Lan, Guoqiang Zhou, Yingmei Qin, Vijay Harypursat, Shunmei Li, Shide Lin, Yaokai Chen
BACKGROUND: This study's objective was to investigate the predictors for severe anemia, severe leukopenia, and severe thrombocytopenia when amphotericin B deoxycholate-based induction therapy is used in HIV-infected patients with talaromycosis. METHODS: A total of 170 HIV-infected patients with talaromycosis were enrolled from January 1st, 2019, to September 30th, 2020. RESULTS: Approximately 42.9%, 20.6%, and 10.6% of the enrolled patients developed severe anemia, severe leukopenia, and severe thrombocytopenia, respectively...
October 20, 2023: BMC Infectious Diseases